BRAINSTORM CELL THERAPEUTICS INC. 10-K filing
Filed 2026-03-31 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001104659-26-037927
- Form type
- 10-K
- CIK
- 0001137883
- Primary document
- https://www.sec.gov/Archives/edgar/data/1137883/000110465926037927/bcli-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BRAINSTORM CELL THERAPEUTICS INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-10.0M | - | - |
| Net Income | $-10.3M | - | - |
| Eps Basic | -1.11 | - | - |
| Eps Diluted | -1.11 | - | - |
| Cash And Equivalents | $29,000 | - | - |
| Total Assets | $1.0M | - | - |
| Total Liabilities | $11.0M | - | - |
| Shareholders Equity | $-10.0M | - | - |
| Operating Cash Flow | $-7.0M | - | - |